Evoqua Water Technologies LLC

Evoqua Water Technologies LLC

Evoqua Water Technologies LLC was formed through a series of corporate carve-outs, ultimately becoming an independent entity under investor ownership. The firm's wealth origin is tied to private equity backing, notably from AEA Investors, which acquired and expanded the business before its eventual sale to Xylem Inc. in 2023 (per Xylem press release, January 2023). The company's Pittsburgh headquarters anchors its North American operations, with additional facilities across the United States and international presence. Evoqua's strategy centers on providing integrated water treatment solutions, spanning chemical treatment, equipment manufacturing, and service contracts. Its asset-class mix includes industrial process water, wastewater recycling, and municipal drinking water systems. The firm's portfolio covers sectors like power generation, pharmaceuticals, food and beverage, and microelectronics. Confirmed large-scale projects include the design and installation of advanced filtration systems for semiconductor fabrication plants and municipal desalination facilities in the U.S. and Middle East (per Evoqua SEC filings, 2022). The firm's approach combines direct equipment sales with long-term service agreements, creating recurring revenue streams. Evoqua's scale is reflected in its pre-acquisition annual revenue of approximately $1.6 billion (per Xylem investor materials, 2022). The company employed over 4,000 professionals globally prior to the Xylem merger. Adjacent vehicles or structures are not publicly disclosed; the firm operated as a standalone entity under AEA Investors before the acquisition. A key recent event was the completion of Xylem's acquisition in May 2023, integrating Evoqua into Xylem's water technology platform and delisting its shares from the NYSE (per SEC filing, May 2023). Evoqua's structural differentiator was its position as a pure-play water technology firm with a broad portfolio, capable of serving diverse end-markets. The acquisition by Xylem created a combined entity with significant cross-selling opportunities and enhanced R&D capabilities. The firm's governance was typical of a private equity-backed industrial company, with a board composition reflecting its investor base.